ArticleDiagnostics (Basel, Switzerland)2026
Integrating Tumor Biology and Host Factors in mCRPC: The Prognostic Value of 'Time to Castration Resistance', Systemic Inflammation, and Comorbidity Burden in Patients Treated with Enzalutamide.
Seda Sali et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.